Spotting red flags in job offers

Here's a quick round up of career articles news and jobs!

Careers Advice

15 Oct - Spotting red flags in job offers

This article discusses how to identify red flags in job offers, including vague job descriptions, unrealistic promises, lack of communication, and pressure tactics.

News

23 Oct - Ten businesses join Discovery Park's Discovery Spark programme

Ten businesses have been selected to participate in the Discovery Spark Programme at Discovery Park in Kent, aimed at supporting early-stage life sciences companies with potential for growth.

23 Oct - Parexel appoints Keri Mattox as Chief Business Officer

Parexel appoints Keri Mattox as Chief Business Officer, bringing extensive experience in life sciences industry to the role.

23 Oct - FDA approves NGS-based diagnostic for IDH mutant glioma

FDA approves NGS-based companion diagnostic for first targeted therapy for patients with grade 2 IDH mutant glioma, offering personalized treatment option for this specific type of brain tumor.

23 Oct - Evotec and Bristol-Myers Squibb Strengthen Proteomics Partnership

Evotec and Bristol Myers Squibb expand partnership to enhance drug discovery using Evotec's cutting-edge proteomics platform.

22 Oct - GSK and Cambridge Univ. partnership in kidney & respiratory disease

GSK and Cambridge University partner for 5 years to research kidney and respiratory diseases, focusing on precision medicine and drug discovery.

21 Oct - Boston Scientific launches next-gen cardiac mapping for Farapulse Pulsed Field Ablation System.

Boston Scientific introduced new cardiac mapping technology for Farapulse Pulsed Field Ablation system, enhancing precision and efficiency in treating cardiac arrhythmias.

21 Oct - Sanofi and CD&R partner for Opella's consumer healthcare ambitions

Sanofi partners with CD&R to support Opella's growth in consumer healthcare, aiming to expand product offerings and deliver innovative solutions to consumers.

21 Oct - Novo Nordisk's Alhemo recommended for EU approval for hemophilia.

Novo Nordisk's Alprolix (emicizumab) recommended for European approval as first once-daily subcutaneous prophylactic treatment for people with hemophilia A or B with inhibitors.

21 Oct - Roche's Vabysmo improves vision in DME populations.

Roche's Vabysmo showed improved vision in underrepresented populations with Diabetic Macular Edema in a groundbreaking study.

21 Oct - Gilead & Merck Phase 2 data on oral combo regimen maintaing viral suppression at week 48

Gilead and Merck announce Phase 2 data showing a treatment switch to oral once-weekly combination regimen of islatravir and lenacapavir maintained viral suppression in adults at week 48.

Latest Jobs

Search 2,226 Pharma & Life Science Jobs - https://bit.ly/48gvuJS

- Clinical Research (616) - https://bit.ly/3A0KuPE

- Sales / Commercial (288) - https://bit.ly/4eVrAsq

- Healthcare (209) - https://bit.ly/3Ump5Hn

- Data Management / Statistics (162) - https://bit.ly/48kiS4C

- Quality (154) - https://bit.ly/3Umy1fX

- R & D (152) - https://bit.ly/4eVrDEC

- Manufacturing (116) - https://bit.ly/3UeXVSD

- Regulatory Affairs (111) - https://bit.ly/3UllYzH

- Finance / Administration (98) - https://bit.ly/3Ump6Lr

- Operations (87) - https://bit.ly/3Ug8QvG

- Medical Affairs (78) - https://bit.ly/3zZyWfx

- Project Management (72) - https://bit.ly/3UlKAYO

- Information Technology (66) - https://bit.ly/3UoadIz

- Marketing (61) - https://bit.ly/3Uoaf39

- Medical Communications (54) - https://bit.ly/4eSphqh

- HEOR (35) - https://bit.ly/40hdehE

- HR / Recruitment / Training (31) - https://bit.ly/3UoahYP

Don't forget to Upload or update your CV - let the jobs come to you! https://bit.ly/3UoajQr

#Pharma #Biotech #ClinicalResearch #LifeSciences #MedicalDevices #Biotechnology #PharmiWeb

cheers - Mike